The Capitals will continue navigating the challenges and advantages that come with a multi-school roster. For many of the ...
TechFinancials on MSN
Vince Trust launches Bitcoin ETF portfolio amid ETF outflows, offering a structured approach to BTC yield generation
London, United Kingdom – As institutional capital continues to flow out of major cryptocurrency exchange-traded funds (ETFs), ...
DUBAI, UAE, Jan. 6, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has ...
Older adults who followed a structured health-related intervention experienced improved sleep-apnea related outcomes compared ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback